Apollon Wealth Management’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
Other funds holding TNDM
SC
FLAM
GKIM
PIM
Apollon Wealth Management's TNDM Position: Q2 2026 in Review
Apollon Wealth Management sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 10,534 shares — an estimated $202K sold.
Apollon Wealth Management first reported a position in TNDM in Q1 2022 and held it in 17 quarters. The position peaked at $2.47M in Q1 2022. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.
- Apollon Wealth Management reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
- Apollon Wealth Management sold 10,534 Tandem Diabetes Care shares in Q2 2026, an estimated $202K.
- Apollon Wealth Management first reported a position in Tandem Diabetes Care in Q1 2022 and held it in 17 quarters.
- Apollon Wealth Management's Tandem Diabetes Care position peaked at $2.47M in Q1 2022.
- 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.
Based on Apollon Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.